Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 199

Similar articles for PubMed (Select 18024662)

1.

Philadelphia chromosome positive acute lymphocytic leukemia: a new era of challenges.

Thomas DA.

Hematology Am Soc Hematol Educ Program. 2007:435-43. Review.

2.

New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemia.

Thomas DA, O'Brien S, Cortes J, Kantarjian H.

Curr Hematol Malig Rep. 2007 Jul;2(3):183-9. doi: 10.1007/s11899-007-0025-z. Review.

PMID:
20425368
3.

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Ottmann OG, Wassmann B.

Hematology Am Soc Hematol Educ Program. 2005:118-22.

4.

Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib.

Tiribelli M, Sperotto A, Candoni A, Simeone E, Buttignol S, Fanin R.

Leuk Res. 2009 Jan;33(1):174-7. doi: 10.1016/j.leukres.2008.03.031. Epub 2008 May 8.

PMID:
18471874
6.
7.

Imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia: current status and evolving concepts.

Ottmann OG, Wassmann B.

Best Pract Res Clin Haematol. 2002 Dec;15(4):757-69. Review.

PMID:
12617875
8.

Targeted therapies in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Hoelzer D, Gökbuget N, Ottmann OG.

Semin Hematol. 2002 Oct;39(4 Suppl 3):32-7. Review.

PMID:
12447850
9.

Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.

Wernstedt P, Brune M, Andersson PO, Gustavsson B, Stockelberg D, Wadenvik H.

Bone Marrow Transplant. 2002 Dec;30(12):971-3.

10.

Treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.

Thomas X, Dombret H.

Leuk Lymphoma. 2008 Jul;49(7):1246-54. doi: 10.1080/10428190801993504. Review.

PMID:
18452076
11.

Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).

Ottmann OG, Wassmann B, Pfeifer H, Giagounidis A, Stelljes M, Dührsen U, Schmalzing M, Wunderle L, Binckebanck A, Hoelzer D; GMALL Study Group.

Cancer. 2007 May 15;109(10):2068-76.

12.

Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

Pfeifer H, Wassmann B, Pavlova A, Wunderle L, Oldenburg J, Binckebanck A, Lange T, Hochhaus A, Wystub S, Brück P, Hoelzer D, Ottmann OG.

Blood. 2007 Jul 15;110(2):727-34. Epub 2007 Apr 3.

13.

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate.

Thomas DA, Faderl S, Cortes J, O'Brien S, Giles FJ, Kornblau SM, Garcia-Manero G, Keating MJ, Andreeff M, Jeha S, Beran M, Verstovsek S, Pierce S, Letvak L, Salvado A, Champlin R, Talpaz M, Kantarjian H.

Blood. 2004 Jun 15;103(12):4396-407. Epub 2003 Oct 9.

14.
15.

In vitro drug resistance to imatinib and mutation of ABL gene in childhood Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia.

Kawaguchi H, Taketani T, Hongo T, Park MJ, Koh K, Ida K, Kobayashi M, Takita J, Taki T, Yoshino H, Bessho F, Hayashi Y.

Leuk Lymphoma. 2005 Feb;46(2):273-6.

PMID:
15621812
16.

Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).

Burke MJ, Cao Q, Trotz B, Weigel B, Kumar A, Smith A, Verneris MR.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1289-94. doi: 10.1002/pbc.22263.

PMID:
19731318
17.

Imatinib for relapsed BCR/ABL positive leukemias.

Ottmann OG, Wassmann B, Hoelzer D.

Ann Hematol. 2002;81 Suppl 2:S36-7. Review. No abstract available.

PMID:
12611069
18.

Existence of leukemic clones resistant to both imatinib mesylate and rituximab before drug therapies in a patient with Philadelphia chromosome-positive acute lymphocytic leukemia.

Hato T, Yamanouchi J, Tamura T, Hojo N, Niiya Y, Kohno M, Bando S, Yakushijin Y, Takada K, Sakai I, Yasukawa M, Fujita S.

Int J Hematol. 2004 Jul;80(1):62-6.

PMID:
15293570
19.

Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Ottmann OG, Pfeifer H.

Hematology Am Soc Hematol Educ Program. 2009:371-81. doi: 10.1182/asheducation-2009.1.371.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk